Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells

References

• Asztalos BF, Schaefer EJ, Horvath KV, et al. (2007). Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res 48:592–9.
   PubMed Web of Science ®Google Scholar
• Bhuiyan MHU, Saidur R, Mostafizur RM, et al. (2015). Experimental investigation on surface tension of metal oxide–water nanofluids. Int Commun Heat Mass Transfer 65:82–8.
   Web of Science ®Google Scholar
• Brandner S, Jaunmuktane Z. (2018). Neurological update: gliomas and other primary brain tumours in adults. J Neurol 265:717–27.
   PubMed Web of Science ®Google Scholar
• Carlucci A, Cigliano L, Maresca B. (2012). LCAT cholesterol esterification is associated with the increase of ApoE/ApoA-I ratio during atherosclerosis progression in rabbit. J Physiol Biochem 68:541–53.
   PubMed Web of Science ®Google Scholar
• Chen R, Cohen AL, Colman H. (2016). Targeted therapeutics in patients with high-grade gliomas: past, present, and future. Curr Treat Options Oncol 17:42.
   PubMed Web of Science ®Google Scholar
• Chu Y, Li D, Luo YF, et al. (2014). Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers. Molecules 19:2445–57.
   PubMed Web of Science ®Google Scholar
• Cooke AL, Morris J, Melchior JT, et al. (2018). A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J. Lipid Res 293:5462–3.
   Google Scholar
• Cui L, Wang Y, Liang M, et al. (2018). Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery. Drug Deliv 25:1865–76.
   PubMed Web of Science ®Google Scholar
• Eavarone DA, Yu X, Bellamkonda RV. (2000). Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J Biomed Mater Res 51:10–4.
   PubMed Web of Science ®Google Scholar
• Florence AT, Halbert GW. (1991). Lipoproteins and microemulsions as carriers of therapeutic and chemical agents. Targeted Diagn Ther 5:141–74.
   PubMedGoogle Scholar
• Gong M, Zhang Q, Zhao Q, et al. (2019). Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy. Drug Deliv 26:708–16.
   PubMed Web of Science ®Google Scholar
• Gordts SC, Singh N, Muthuramu I, Geest BD. (2013). Pleiotropic effects of HDL: towards new therapeutic areas for HDL-targeted interventions. Curr Mol Med 14:6744–53.
   Web of Science ®Google Scholar
• Holmquist L. (2002). Selective extraction of lecithin:cholesterol acyltransferase (EC 2.3.1.43) from human plasma. J Biochem Biophys Methods 52:64–8.
   Google Scholar
• Holmquist L, Carlson K. (1977). Selective extraction of human serum very low density apolipoproteins with organic solvents. Biochim Biophys Acta 493:400–9.
   PubMed Web of Science ®Google Scholar
• Hong SC, Zhao SP, Wu ZH. (2007). Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits. Int J Cardiol 115:29–35.
   PubMed Web of Science ®Google Scholar
• Hughes DP. (2009). Expert opinion on drug delivery: strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv 6:1311–21.
   PubMed Web of Science ®Google Scholar
• Kostner GM, Knipping G, Groener JEM, et al. (1987). The role of LCAT and cholesteryl ester transfer proteins for the HDL and LDL structure and metabolism. Adv Exp Med Biol 210:79–86.
   PubMedGoogle Scholar
• Kratzer I, Wernig K, Panzenboeck U, et al. (2007). Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood–brain barrier. J Control Release 117:301–11.
   PubMed Web of Science ®Google Scholar
• Laccotripe M, Makrides SC, Jonas A, Zannis VI. (1997). The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J Biol Chem 272:17511–22.
   PubMed Web of Science ®Google Scholar
• Lavrador JP, Oliveira E, Pimentel J, Livraghi S. (2017). Adult pilocytic astrocytoma of conus medullaris: clinical considerations and review of the literature. CNS Oncol 6:107–10.
   PubMedGoogle Scholar
• Lin L, Cai J, Jiang C. (2017). Recent advances in targeted therapy for glioma. Curr Med Chem 24:1365–81.
   PubMed Web of Science ®Google Scholar
• Lu H, Zhang H, Zhang D, et al. (2015). A biocompatible reconstituted high-density lipoprotein nano-system as a probe for lung cancer detection. Med Sci Monit 21:2726–33.
   PubMed Web of Science ®Google Scholar
• Lund-Katz S, Liu L, Thuahnai ST, Phillips MC. (2003). High density lipoprotein structure. Front Biosci 8:d1044–d54.
   PubMed Web of Science ®Google Scholar
• Marsche G. (2015). It’s time to reassess the high-density lipoprotein (HDL) hypothesis: CSL112, a novel promising reconstituted HDL formulation. J Am Heart Assoc 4:68–76.
   Web of Science ®Google Scholar
• Nicholls SJ, Puri R, Nissen SE. (2018). High-density lipoprotein-targeted therapies-not dead yet-reply. JAMA Cardiol 3:1255–6.
   PubMed Web of Science ®Google Scholar
• Nobecourt E, Davies MJ, Brown BE, et al. (2007). The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia 50:643–53.
   PubMed Web of Science ®Google Scholar
• Oda MN, Hargreaves PL, Beckstead JA, et al. (2006). Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B. J Lipid Res 47:260–7.
   PubMed Web of Science ®Google Scholar
• Park KH, Yun CO, Kwon OJ, et al. (2010). Enhanced delivery of adenovirus, using proteoliposomes containing wildtype or V156K apolipoprotein A-I and dimyristoylphosphatidylcholine. Hum Gene Ther 21:579–87.
   PubMed Web of Science ®Google Scholar
• Pedersbaek D, Kraemer MK, Kempen PJ, et al. (2019). The composition of reconstituted high-density lipoproteins (rHDL) dictates the degree of rHDL cargo- and size-remodeling via direct interactions with endogenous lipoproteins. Bioconjug Chem 30:2634–46.
   PubMed Web of Science ®Google Scholar
• Peitsch MC, Kress A, Lerch PG, et al. (1989). A purification method for apolipoprotein A-I and A-II. Anal Biochem 178:301–5.
   PubMed Web of Science ®Google Scholar
• Petri B, Bootz A, Khalansky A, et al. (2007). Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release 117:51–8.
   PubMed Web of Science ®Google Scholar
• Qian W, Qian M, Wang Y, et al. (2018). Combination glioma therapy mediated by a dual-targeted delivery system constructed using OMCN-PEG-Pep22/DOX. Small 14:123–32.
   Web of Science ®Google Scholar
• Rajora MA, Zheng G. (2016). Targeting SR-BI for cancer diagnostics, imaging and therapy. Front Pharmacol 7:326.
   PubMed Web of Science ®Google Scholar
• Song Q, Huang M, Yao L, et al. (2014). Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer’s disease by accelerating the clearance of amyloid-beta. ACS Nano 8:2345–59.
   PubMed Web of Science ®Google Scholar
• Tosheska Trajkovska K, Topuzovska S. (2017). High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol. Anatol J Cardiol 18:149–54.
   PubMed Web of Science ®Google Scholar
• Tsompanidi EM, Brinkmeier MS, Fotiadou EH, et al. (2010). HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis 208:3–9.
   PubMed Web of Science ®Google Scholar
• Vaisar T, Pennathur S, Green PS, et al. (2007). Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 117:746–56.
   PubMed Web of Science ®Google Scholar
• Wang J, Jia J, Liu J, et al. (2013). Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins. Drug Deliv 20:356–63.
   PubMed Web of Science ®Google Scholar
• Xu Y, Jin X, Ping Q, et al. (2010). A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. J Control Release 146:299–308.
   PubMed Web of Science ®Google Scholar
• Yang ZZ, Li JQ, Wang ZZ, et al. (2014). Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Biomaterials 35:5226–39.
   PubMed Web of Science ®Google Scholar
• Yang F, Zou Y, Gong Q, et al. (2020). From astrocytoma to glioblastoma: a clonal evolution study. FEBS Open Bio 56:23–32.
   Google Scholar
• Zhang Y. (2004). Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10:3667–77.
   PubMed Web of Science ®Google Scholar
• Zhu C, Kros JM, Cheng C, Mustafa D. (2017). The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies. Neuro Oncol 19:1435–46.
   PubMed Web of Science ®Google Scholar